Internal Medicine, Infectious Disease · Douglasville, GA
NPI
1194884916
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
6043 Prestley Mill Rd, Suite C
Douglasville, GA, 30134
Phone (770) 920-3076
Groups this clinician bills Medicare through
Medicare paid, 2024
$138K
1,728 services
Medicare patients, 2024
273
Average age 72
Drug cost, 2024
$2.3M
1,475 prescriptions
Company payments, 2023
$16.24
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christopher J Watts was code 99232 (hospital e&m - subsequent), 709 times for 134 patients. In total Christopher J Watts billed 1,728 services in 18 codes, and Medicare paid $138K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-05-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 709 | 134 | $63.22 | $45K |
| 99231 Hospital E&M - Subsequent | Facility | 208 | 85 | $38.93 | $8,096 |
| 99223 Hospital E&M - Initial | Facility | 207 | 158 | $138.47 | $29K |
| 99214 Office E&M - Established | Office | 175 | 95 | $93.10 | $16K |
| 99233 Hospital E&M - Subsequent | Facility | 143 | 64 | $94.46 | $14K |
| 11042 Debridement | Office | 96 | 14 | $102.28 | $9,819 |
| 99213 Office E&M - Established | Office | 51 | 45 | $72.87 | $3,716 |
| 99204 Office E&M - New | Office | 47 | 47 | $125.25 | $5,887 |
By year: 2022 $156K for 2,174 services; 2023 $140K for 1,829 services; 2024 $138K for 1,728 services.
Medicare prescription drug claims, 2024
In 2024, the drug Christopher J Watts prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 278 prescriptions and refills. In total Christopher J Watts wrote 1,475 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 278 | 278 | 36 | $1.1M |
| Levofloxacin Generic | 74 | 81 | 50 | $398 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 62 | 73 | 29 | $494 |
| Cefdinir Generic | 61 | 64 | 43 | $980 |
| Tivicay Dolutegravir Sodium | 61 | 61 | Under 11 | $144K |
| Doxycycline Hyclate Generic | 54 | 61 | 37 | $709 |
| Descovy Emtricitabine/Tenofov Alafenam | 48 | 52 | Under 11 | $116K |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 43 | 43 | Under 11 | $179K |
| Fluconazole Generic | 41 | 41 | 25 | $407 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 40 | 40 | Under 11 | $161K |
| Isentress Raltegravir Potassium | 39 | 43 | Under 11 | $85K |
| Rifampin Generic | 36 | 36 | Under 11 | $965 |
| Prezcobix Darunavir/Cobicistat | 34 | 34 | Under 11 | $91K |
| Zidovudine Generic | 33 | 33 | Under 11 | $3,502 |
| Emtricitabine-Tenofovir Disop Emtricitabine/Tenofovir (Tdf) | 29 | 29 | Under 11 | $6,409 |
Brand drugs: 650 claims; generic drugs: 825 claims.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Christopher J Watts $16.24 ($16.24 in general payments such as food, travel and fees) from 1 company. The largest payer was Insmed, Inc. with $16.24.
| Company | Payments | Amount |
|---|---|---|
| Insmed, Inc. INSM | 1 | $16.24 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.